Skip to main content
. 2022 Mar 4;9:839090. doi: 10.3389/fcvm.2022.839090

Table 1.

Clinical characteristics and CMR findings of the study patients.

Age (ye- ars) Sex Past medi- cal his- tory Symp- toms ECG Peak Tro- ponin (ng/L) CAD ruled out Time from 3rd vaccine and symp- toms (days) Time bet- ween 3rd vaccine and MRI (days) LVEF % Wall motion abnorm- ality LVEDV/ BSA LVESV/ BSA LV- mass/ BSA T1 global (ms) T1 focal (ms) T2 global (ms) T2 focal (ms) Global ECV (%) Focal ECV (%) LGE (%) LGE local- ization LGE pat-tern LGE in peri- card Peri- car- dial effu- sion Dia- meter of effu- sion (mm)
21 M None Chest pain Infe- rior STE 240 CA 4 8 53 Lateral wall 73.5 33.9 49.6 1,078 ± 107 1,135 ± 118 62 ±
8
69.2 30.1 36 9 Antero- lateral, infero- lateral (basal,
mid) Lateral (apical)
Epicar-
dial and mid-wall
Y N
44 F None Chest pain Nor- mal 80 CCT 2 40 63 N 70.6 25.8 31.7 1,039 ± 70 1,077 ± 66 52.4 ± 6 57.5 30.5 31.9 1 Apex, infero- septal (basal) Mid-wall Y N
26 M As-
thma
Chest pain Diff- use STE 4,967 N 14 47 71 N 76.7 22.2 46.9 1,045 ± 93 1,155 ± 89 50 ± 6.7 58.1 34.2 44.9 3 Inferior
and
infero- lateral (basal)
Epicar-
dial
N Circular 5
18 M None Chest pain Diff- use STE 79 CCT 3 42 59 N 74 31.4 45.8 1,008 ± 70 1,041 ± 80 49 ± 4.4 57.4 27.3 29.3 1 Inferior (basal) Epicar-
dial
N Circular 4

M, male; Y, yes; N, no; LV, left ventricular; LVEDV, left ventricular end-diastolic volume; ECG, electrocardiogram; LVESV, left ventricular end-systolic volume; BSA, body surface are; LGE, late gadolinium enhancement; CAD, coronary artery disease; CA, coronary angiography; CCT, cardiac computed tomography; STE, ST-segment elevation.